Investcorp, a global alternative investment firm, has made an investment in V-Ensure Pharma Technologies (V-Ensure), in a transaction valued at INR1.3 billion (approximately USD17.5 million).
The round was led by Investcorp along with participation from Asia-based private investment firm, Tanas Capital.
This marks Investcorp’s third healthcare investment in India and its first in the pharmaceutical sector.
This investment will fund V-Ensure’s objective of pursuing growth opportunities across North America, Europe and other global markets for the development and launch of its products. The investment also reinforces Investcorp’s commitment to invest in market-leading business services, information technology and healthcare businesses in India and accelerate their expansion and competitive positioning globally.
Investcorp has been active in the mid-market private equity space in India since 2019, investing across the healthcare, businesses services, financial services, consumer & retail, and technology sectors. Its investments over the last four years include Nephroplus, Wingreens, Intergrow Brands, Bewakoof.com, FreshToHome, Zolostays, InCred, Citykart, ASG Eye Hospital, Unilog, Xpressbees, and Safari Industries.
